title: Endothelial dysfunction in Type 2 diabetic subjects with and without microalbuminuria.
abstract: OBJECTIVE
  The primary aim of this study was to determine whether microalbuminuria is associated with endothelial dysfunction in Type 1 diabetes mellitus. The secondary aim was to determine whether any reported biochemical markers of cardiovascular risk are associated with endothelial dysfunction in this group.
  
  
  METHODS
  Measurements were made of the vasodilatory responses of the brachial artery to post-ischaemic hyperaemia and to sublingual glyceryl trinitrate (GTN) (causing endothelium-dependent and endothelium-independent dilation, respectively) using a high-resolution ultrasound technique in 18 Type 1 diabetic patients with microalbuminuria, 18 age and sex-matched normoalbuminuric Type 1 diabetic patients and 18 non-diabetic control subjects.
  
  
  RESULTS
  There was a significant reduction in flow-mediated dilation (FMD) in microalbuminuric and normoalbuminuric diabetic patients compared with control subjects (2.4% (95% confidence interval (CI) 1.0-3.8%) and 2.3% (95% CI 0.7-3.9%) respectively vs. 6.3% (95% CI 5.1-7.5%), P<0.0001) but no difference in GTN-mediated dilation (14.7% (95% CI 10.7-18.7%) and 15.2% (95% CI 11.2-19.2%) vs. 18.7% (95% CI 16.1-21.3%), P = 0.09). There was no significant difference in FMD, however, between the microalbuminuric group and normoalbuminuric group (P=0.45). FMD was not significantly associated with urinary albumin-creatinine ratio, glycosylated haemoglobin, plasma glucose, lipid or lipoprotein concentrations in diabetic patients. There was a positive correlation between active transforming growth factor (TGF)-beta concentration, a novel biochemical marker of macrovascular disease, and FMD in diabetic patients (r=0.36, P<0.05). GTN-mediated dilation was positively associated with HDL-cholesterol concentration (r = 0.49, P = 0.002) but not with other biochemical variables (including active TGF-beta concentration). Active TGF-beta concentration was not associated with degree of microalbuminuria or other biochemical parameters.
  
  
  CONCLUSIONS
  These data suggest that endothelial dysfunction occurs in Type 1 diabetic patients regardless of urine albumin status. Endothelial dysfunction appears therefore to predate the development of microalbuminuria as a marker for the development of coronary artery disease. It is also concluded that low plasma levels of active TGF-beta are associated with an impaired endothelial response and this may provide a useful tool for identifying Type 1 diabetic patients at a greater risk of coronary artery disease.
authors.affiliation: Department of Diabetes, Queen Alexandra Hospital, Portsmouth, UK.
authors.forename: D R
authors.initials: DR
authors.lastname: Meeking
authors.forename: M H
authors.initials: MH
authors.lastname: Cummings
authors.forename: S
authors.initials: S
authors.lastname: Thorne
authors.forename: A
authors.initials: A
authors.lastname: Donald
authors.forename: P
authors.initials: P
authors.lastname: Clarkson
authors.forename: J R
authors.initials: JR
authors.lastname: Crook
authors.forename: G F
authors.initials: GF
authors.lastname: Watts
authors.forename: K M
authors.initials: KM
authors.lastname: Shaw
mesh_terms: D000328:Adult; D000419:Albuminuria / Q000503:physiopathology*; D001916:Brachial Artery / Q000503:physiopathology; D008076:Cholesterol, HDL / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000503:physiopathology*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D006940:Hyperemia; D007328:Insulin / Q000627:therapeutic use; D007511:Ischemia; D008297:Male; D005996:Nitroglycerin; D016212:Transforming Growth Factor beta / Q000097:blood; D014664:Vasodilation; D014665:Vasodilator Agents
chemical_list: D008076:Cholesterol, HDL; D006442:Glycated Hemoglobin; D007328:Insulin; D005996:Nitroglycerin; D016212:Transforming Growth Factor beta; D014665:Vasodilator Agents